Skip to main navigation Skip to search Skip to main content

Differences in lung bioavailability between HFA and CFC formulations of fluticasone propionate

Research output: Contribution to journalArticle

20 Citations (Scopus)
Original languageEnglish
Pages (from-to)1357-1358
Number of pages2
JournalLancet
Volume354
Issue number9187
DOIs
Publication statusPublished - 1999

Cite this